ing Nanog expression in epiblast cells during gastrulation. Nanog expression in primordial germ cells is not regulated by this pathway, indicating that these two cell types employ different mechanisms for maintaining pluripotency in early development. Furthermore, our data suggest that the bHLH factor E2A plays a role in negatively regulating Nanog expression in vivo. Overall, our data support a direct and positive role of the Smad2/3 mediated TGF-beta signaling pathway in inducing/maintaining Nanog expression.
Introduction
Nanog is a homeodomain protein critical for maintaining pluripotency in embryos and cultured cells (Chambers et al., , 2007 Mitsui et al., 2003; Wang et al., 2003) . First described in mice, Nanog homologs have been found in mammals, birds and teleosts (Booth and Holland, 2004; Camp et al., 2009; Canon et al., 2006; Fairbanks and Maughan, 2006; Hart et al., 2004; Robertson et al., 2006) . In addition to cultured embryonic stem (ES) cells, the epiblast during early gastrulation and the primordial germ cells (PGCs) during their migration and colonization of somatic gonad require Nanog for pluripotency maintenance (Chambers et al., , 2007 Mitsui et al., 2003; Yamaguchi et al., 2005) . Nanog-null mouse embryos die at E5.5 due to early differentiation of epiblast cells into primitive endoderm prior to the onset of gastrulation Mitsui et al., 2003) . The loss of Nanog expression in the mouse epiblast (at E7.5) coincides with robust mesoderm formation from the epiblast through gastrulation Hatano et al., 2005; Medvedev et al., 2008; Mitsui et al., 2003) , suggesting that Nanog functions in gastrulation-stage epiblast to prevent early mesoderm and neural ectoderm differentiation (Boiani and Scholer, 2005; Suzuki et al., 2006; Vallier et al., 2009) . In chickens, there are two Nanog related genes (Nanog and Nanoglike1) (Canon et al., 2006) . Chicken Nanog was reported to be expressed in pre-streak epiblast cells and down-regulated during gastrulation (Lavial et al., 2007) , and is considered to be the molecular and functional ortholog of mammalian Nanog (Canon et al., 2006; Lavial et al., 2007) . Molecular regulation of Nanog gene expression has been studied primarily using ES cells. Two other pluripotency associated genes, Oct4 and Sox2, have been suggested to form a mutually regulatory loop with Nanog (Boiani and Scholer, 2005; Boyer et al., 2005; Kuroda et al., 2005; Loh et al., 2006; Pan and Thomson, 2007; Rodda et al., 2005) . Several other transcription factors, including Sall4, FoxD3, p53, and Tcf3, have been implicated in regulating Nanog gene expression (Cole et al., 2008; Hanna et al., 2002; Lim et al., 2008; Liu and Labosky, 2008; Pan and Thomson, 2007; Pereira et al., 2006; Wu et al., 2006) . Signal-wise, Nanog expression levels have been reported to be modulated in various systems by LIF, Wnt, BMP, FGF, retinol and Activin/Nodal TGF-beta pathways (Boiani and Scholer, 2005; Chen et al., 2007 Chen et al., , 2008 Kunath et al., 2007; Okita and Yamanaka, 2006; Sato et al., 2004; Silva et al., 2008; Suzuki et al., 2006; Takao et al., 2007; Vallier et al., 2009; Xu et al., 2008; Yi et al., 2008; Ying et al., 2008) . Despite these in vitro studies, the regulation of Nanog expression in vivo is not well understood.
In this work, we used gastrulation-stage chick epiblast as a model and investigated Nanog regulation in vivo. Epiblastspecific expression of chicken Nanog is blocked by a TGF-beta signaling pathway inhibitor, SB431542, whereas PGC-specific expression of Nanog is not affected by this inhibitor. Ectopic activation of the TGF-beta pathway induces Nanog expression and forced over-expression of a bHLH transcription factor, E2A, reduces endogenous Nanog. We conclude that Nanog expression is regulated by different mechanisms in the epiblast and PGCs, and that epiblast Nanog expression requires the TGF-beta signaling activity.
2.
Results and discussion 2.1.
Expression pattern of chicken Nanog in the epiblast during gastrulation
Chicken Nanog was first reported as a germ cell specific gene (Canon et al., 2006) and was later shown to be expressed in addition in the pre-streak epiblast and in cultured chicken ES cells (Lavial et al., 2007) , similar to the expression pattern reported for mouse Nanog Hart et al., 2004; Mitsui et al., 2003; Yamaguchi et al., 2005) . Functionally, chicken Nanog can replace mouse Nanog in maintaining LIFindependent proliferation of mouse ES cells and is required for maintaining the pluripotency of chicken ES cells (Lavial et al., 2007) . We first confirmed that the other Nanog related gene, Nanog like-1, as reported previously (Canon et al., 2006) , is not expressed in the epiblast during gastrulation (data not shown). We then investigated in more detail the dynamic expression of the chicken Nanog gene during the critical window from stage HH3 to stage HH6, when epiblast pluripotency is rapidly lost. At HH3 and HH3+, Nanog expression is still detected prominently in all epiblast cells (Fig. 1A) , with stronger expression in the area pellucida. Epiblast cells located at the primitive streak, undergoing epithelial-tomesenchymal transition, have a reduced level of Nanog expression (Fig. 1B) . Mesoderm cells do not express Nanog (Fig. 1B) , except for the germ cells located within the mesoderm population. As reported previously (Lavial et al., 2007) , a majority of germ cells are closely associated with the hypoblast and are strongly positive for Nanog ( Fig. 1B and C arrow heads). Medial epiblast expression of Nanog is still prominent at HH4 and this expression is rapidly lost between stage HH4 and HH5, leaving only the anterior neural plate positive for Nanog ( Fig. 1A and C) at HH6. Lateral epiblast cells, in the area opaca and lateral area pellucida regions, maintain weak levels of expression (Fig. 1A and C) , and PGCs have strong Nanog expression throughout this period (arrows in Fig. 1A ; arrowheads in Fig. 1B and C).
2.2.
Inhibition of Nanog expression in the medial epiblast by SB431542
These observations indicated that Nanog expression in the medial epiblast, lateral epiblast and PGCs may be regulated differently. We then asked which signals are important for Nanog expression during gastrulation in the medial epiblast, from which all embryonic tissues are derived. A number of signaling pathways have been implicated in regulating Nanog expression in vitro (see Section 1). Two recent reports suggested that in human ES cells, Activin/Nodal TGF-beta signaling can directly control Nanog expression (Vallier et al., 2009; Xu et al., 2008) . We tested whether Nanog expression during early chick development is affected by SB431542, a potent and specific inhibitor for Activin receptor likekinase receptors Inman et al., 2002) . Embryos incubated for six hours in the presence of SB431542 from early HH3 to late HH3 resulted in a dramatic reduction of Nanog expression in the medial epiblast cells (Fig. 1I) , in contrast to control DMSO treated embryos which showed normal Nanog expression (Fig. 1D) . A similarly strong inhibition of Nanog expression was seen when SB505124, another specific inhibitor for Activin receptor like-kinase receptors, was used (Fig. 1K) . Interestingly, the weak expression of Nanog in the lateral epiblast and the strong expression in PGCs were not affected by this treatment (Fig. 1I-K) . The inhibition of medial epiblast specific Nanog expression was rapid, as an obvious down regulation was seen by 2 h treatment of this inhibitor ( Fig. 2A) . This inhibition was also observed in pre-streak stage embryos (Fig. 2B) . No gross morphological defect was seen with 6-h treatment at HH3 (Fig. 2A) , although treatment of this inhibitor from pre-streak stage to HH3 led to defects in streak formation (data not shown). When similarly cultured for 6 h from early HH3 to late HH3, Nanog expression in the medial epiblast did not show an obvious change by the BMP pathway specific inhibitor Dorsomorphin (Fig. 1E) , the FGFR inhibitor SU5402 (Fig. 1F) , the MAPKK inhibitor PD98059 (Fig. 1G) or by JNK inhibitors SP600125 (Fig. 1H ) and SB203580 (data not shown). Phospho-Smad2 immunostaining revealed a strong reduction of Smad2/3 mediated TGF-beta signaling activity in SB431542 (4 h) treated embryos ( Fig. 2D and F) in comparison to control DMSO treated embryos ( Fig. 2C and E) . Residual signals of phospho-Smad2 could still be observed in streak epiblast cells. This is consistent with our observation that residual Nanog expression around the streak was present after 3-h SB431542 treatment ( Fig. 2A) , but was completely lost after 6-h treatment (Fig. 1I ). These data suggested that the Activin/TGF-beta pathway plays an important role in vivo in maintaining the expression of Nanog in medial epiblast cells.
2.3.
Positive regulation of Nanog expression in the epiblast by exogenous Activin and constitutively active (CA)-ALK4
We next asked whether ectopic activation of the TGF-beta pathway is sufficient to induce or up-regulate Nanog expression. Stage HH3 embryos were grafted with beads soaked with various purified recombinant proteins in the lateral regions where only weak Nanog expression is detected in normal embryos, and were further cultured for 6 h. Control BSA did not affect Nanog expression (Fig. 3A and J) . Human ActivinB proteins were able to consistently increase the levels of Nanog expression ( Fig. 3B and K) , whereas human TGF-beta1, human TGF-beta2 (data not shown), mouse Nodal (Fig. 3C) or human TGF-beta3 (Fig. 3D) did not have an obvious effect. Human GDF3 elicited a very weak increase, and mouse Nodal and human TGF-beta3 proteins were confirmed to be active in a separate control assay (data not shown). The increase in Nanog by Activin proteins was also observed in HH4 + embryos (compare Fig. 3F with Fig. 3E and G) , which have reduced levels of endogenous Nanog expression in the medial epiblast (Fig. 3E) . Confirming the ability of Activin/TGF-beta signal pathway to positively regulate Nanog expression, epiblast cells electroporated with a DNA construct expressing CA-ALK4 (an Activin specific type 1 receptor) showed a strong increase in Nanog expression levels (Fig. 3H , section in Fig. 3L  and M) . A similar increase in Nanog expression was seen when CA-ALK4 was introduced to epiblast cells in the presence of SB431542 (Fig. 3Q and R) or at later stages (Fig. 3S) . Supporting the hypothesis that ALK4 is involved in regulating Nanog expression, endogenous Alk4 was observed to be expressed in the medial epiblast during early chick development ( Fig. 3O and P) .
These data suggested that TGF-beta pathway activity is required for Nanog expression in medial epiblast cells and that exogenous activation of Activin mediated TGF-beta signaling is sufficient to induce/up-regulate Nanog expression. However, we cannot rule out other TGF-beta superfamily members as possible inducers. The requirement for a co-receptor for Vg1 and Nodal mediated TGF-beta pathway activation may mask their inducing ability in our assay. The loss of Nanog between HH4 to HH5 starts from cells adjacent to the primitive streak, suggesting that a possible cause is the loss of inducing signals from the primitive streak. Grafted HH3-4 streak tissues were able to increase Nanog expression levels in lateral epiblast cells (Fig. 3I and N) , regardless of the A/P level of either the graft tissue or host region. Both endogenous and induced expression by grafted streak tissues could be inhibited by SB431542 treatment and this inducing ability was significantly reduced in HH5 streak tissues (data not shown). During early mouse development, Nanog expression in pre-gastrulation stage epiblast is down-regulated in Nodalnull mutant embryos (Mesnard et al., 2006) . This suggests that Nodal signal from the visceral endoderm and young epiblast in mouse embryos may serve as an endogenous inducer of Nanog expression. It is unclear, however, whether this regulation is direct or not, or whether Nanog expression in the epiblast during gastrulation is regulated through the same mechanism. In chick embryos, Vg1 and Nodal transcripts were reported to be expressed in the elongating primitive streak and to be lost during streak regression (Bertocchini and Stern, 2002; Seleiro et al., 1996; Shah et al., 1997; Skromne and Stern, 2002) . However, Chicken Vg1 and Nodal have restricted expression at the region of streak initiation at HH1, whereas Nanog is broadly expressed in area pellucida epiblast at this stage. Chicken type II Activin receptors (cActRIIA and cActRIIB) have been reported to be expressed in streak stages embryos (Stern et al., 1995) . Chicken Activin bA was not detected in early stage embryos, whereas chicken Activin bB was reported to have a posterior-restricted expression at late prestreak stage (Levin, 1998) . It is therefore unclear what are the endogenous inducing signals for Nanog expression in prestreak stage chick embryos.
Forced overexpression of E2A downregulates Nanog expression in the epiblast
In addition to inducing signals, Nanog expression in epiblast cells may be regulated by active inhibition, through either extra-cellular inhibitory signals or intra-cellular negative regulatory mechanisms. Testing of a number of secreted molecules, although not exhaustive, did not yield an obvious candidate for the inhibition of Nanog gene expression. In testing possible positive/negative intra-cellular regulators, however, we found that a ubiquitous bHLH transcription factor, E12 (encoded by the E2A gene), can function as a negative regulator of Nanog expression. E2A is expressed in area pellucida epiblast like Nanog from HH1 to HH3 (Fig. 4A) , with weak expression in the area opaca and in newly formed mesoderm cells, and with no expression in the endoderm layer ( Fig. 4A  and G) . From HH4 to HH6, E2A expression levels increase further in the medial epiblast where Nanog expression is rapidly down-regulated. E2A has been reported to act either as a transcription activator or repressor, depending on its binding partner. Due to the difficulty in electroporating early stage chick embryos, we were unable to test this hypothesis at stage HH1 or HH2. Ectopic expression of E12 (one of two E2A encoded proteins) from HH3 to HH4 was able to potently inhibit Nanog expression (compare Fig. 4D-F with Fig. 4B and C; section of 4E shown in 4H), suggesting that E2A during early development negatively regulates the Nanog expression level. However, attempts to knockdown E2A expression using morpholino oligos did not lead to an up-regulation of Nanog expression (data not shown). Furthermore, Activin beads did not affect the endogenous E2A expression (Fig. 5A and B) . Nor was E2A expression affected by SB431542 treatment (Fig. 5C-F) . These data suggested that E2A may affect Nanog expression indirectly and via mechanisms different from the TGF-beta pathway. In cultured ES cells, E2A was reported to be associated with the loss of pluripotency with a putative role in inhibiting functions of Id proteins (Ying et al., 2003) . Forced overexpression of Id proteins can bypass serum requirement for ES cell self-renewal and forced overexpression of E2A inhibits self-renewal and promotes differentiation (Ying et al., 2003) . At least two of four reported chicken Id genes, Id1 and Id2, are expressed at HH3-4 in the epiblast (Fig. 4I and J) . Over-expression of Id2 was able to increase endogenous Nanog expression levels at HH4 (Fig. 5G, H , and K), although no induction in the epiblast was seen by Id2 at later stages ( Fig. 5I and J) when endogenous Nanog expression disappears. These data indicated that balancing E2A and Id protein/activity levels may serve as a possible mechanism for the negative regulation of Nanog gene expression in gastrulating stage epiblast cells.
In summary, our data provide in vivo evidence for the involvement of Activin/TGF-beta pathway in regulating medial epiblast specific expression of Nanog during gastrulation, supporting the model proposed from in vitro studies of a direct role of the TGF-beta pathway in Nanog transcriptional regulation (Vallier et al., 2009; Xu et al., 2008) . All embryonic tissues in the three germ layers are derived from the medial epiblast in amniotes. The loss of Nanog expression in the medial epiblast coincides with the completion of primitive streak extension and of the specification of mesodermal precursor cells within the epiblast population, Figure 5 -Activin or SB431542 does not affect E2A expression and Id2 over-expression up-regulates Nanog expression. (A and B) Neither human Activin B soaked beads (B) nor control beads (A) have an effect on E2A expression after 6-h culture. Insets are increased contrast views, showing the location of grafted beads. (C-F) Six hours SB431542 treatment has no effect on E2A expression either at stage HH2 (D) or HH4 (F). Panels C and E are controls for D and F, respectively. (G-I) Id2 over-expression upregulates endogenous Nanog expression at HH4 (G: before Id2 protein staining; H: after Id2 protein staining), but not at HH6 (I: before; J: after). K): Section through the level indicated in H. (L) A model for the putative link between pluripotency maintenance in the epiblast on the one hand, and gastrulation and mesoderm/ectoderm differentiation on the other. Signals regulating the pluripotency can be conceptually separated from those regulating mesoderm induction, neural induction, primitive streak formation or gastrulation movement. Pluripotency maintenance in epiblast cells does not prevent these cells from receiving initial inductive cues or expressing early germ layer specific markers. From stage HH1 to HH4, medial epiblast cells (green) gradually lose their pluripotency. During the same period, mesoderm and ectoderm precursor territories are being allocated concurrent with the gastrulation movement, and mesoderm and ectoderm (mainly neural ectoderm) precursors initiate their differentiation process, without committing to either lineage before a global loss of epiblast pluripotency after HH4. Pluripotency marker Nanog is positively regulated by TGF-beta signaling activity and negatively regulated by E2A. The precise role of E2A/Id2 balance in Nanog regulation awaits further elucidation (represented by dashed lines). c after which the epiblast cells are further patterned into medial neural ectoderm and lateral non-neural ectoderm, and mesoderm precursor cells in the primitive streak undergo epithelial-to-mesenchymal transition to become true mesoderm cells (Boiani and Scholer, 2005; Sheng et al., 2003; Suzuki et al., 2006; Vallier et al., 2009) . The function of Nanog in the medial epiblast, as suggested from ES cell studies, may therefore be to modulate differentiation potentials of epiblast cells when germ layer specification and early patterning events are actively taking place (Fig. 5L) . It is worth noting that a similar coordination between germ layer specification and patterning on the one hand and modulation of differentiation potentials on the other needs to be achieved during early development not only in amniotes, but in all vertebrates. Indeed, functional orthologs of Oct4, Sox2 and several other pluripotency associated genes have been reported in both amniote and non-amniote species. A recent publication reported the presence of Nanog orthologs in teleost fish (Camp et al., 2009) , suggesting that Nanog's role in pluripotency maintenance may have a pre-amniote origin. It will be interesting, therefore, to understand whether the more ''primitive'' role of Nanog is to regulate the pluripotency of the PGCs or of the epiblast cells.
Experimental procedures
Fertilized eggs were purchased from Shiroyama Farm (Kanagawa, Japan). Chick embryos were explanted using the New culture method and incubated at 38.5°C (Stern and Ireland, 1981) . Embryonic tissue graft, bead graft, electroporation, chemical treatment and RNA in situ hybridization were carried out using standard methods as described previously (Nakazawa et al., 2006; Shin et al., 2009; Stern, 1998; Streit and Stern, 2001 combined with Cy3-TSA plus system as described in Shin et al., 2009 . This antibody may cross-react with p-Smad3, according to company product information, but not with other phospho-Smads. The Nanog in situ probe was made against the exact coding region of DQ867025 based on published information (Lavial et al., 2007) . A Nanog-like1 gene fragment for making in situ probe, corresponding to putative amino acids 78-308 in sequence alignment (Canon et al., 2006) , was generated by PCR from stage HH7 cDNA using the following two primers: 5 0 AGCCAGTTCATGCCAGACTT-3 0 and 5 0 -GGGCTGACTGGTG-GAAGTTA-3 0 . The Alk4 in situ probe was made against nucleotides 1339-1841 of XM_001231300. Id1 in situ probe was made against nucleotides 737-910 of NM_204590, and Id2 in situ probe against nucleotides 167-1005 of NM_205002. For overexpression of E2A, the open reading frame of chicken E12 was cloned from HH5-7 cDNA library by PCR and confirmed by sequencing. It was inserted into pCAGGS vector and fused with the eGFP gene at the C-terminal end of E12 by using the Gateway system (Invitrogen, US). Constitutively active (CA)-ALK4 was cloned into pCAGGS vector from pcDNA-human-CA-ALK4-HAtag (Gift from H. Kondo, Osaka Univ, Japan) and overexpression was detected by anti-HA tag antibody. Id2 expression construct was made by cloning full length chicken Id2 gene, corresponding to nucleotides 76-480 of NM_205002, into the pCAGGS vector.
